Market Overview

UPDATE: J.P. Morgan Raises PT on Merck & Co. to $44 (MRK)


J.P. Morgan is out with its report today on Merck & Co. (NYSE: MRK), raising its PT from $42 to $44.

In a note to clients, J.P. Morgan writes, "We are increasing our MRK sales and EPS estimates following strong 1Q/11 results. Our new estimates are toward the high end of the company's 2011 guidance range. We are raising our PT by $2 to $44.

J.P. Morgan maintains Overweight on MRK.

Shares of MRK closed Friday at $35.95, up 0.50% from Thursday's close.

Posted-In: J.P. Morgan Merck & Co.Analyst Color Analyst Ratings


Related Articles (MRK)

View Comments and Join the Discussion!

Latest Ratings

NXTCBank of AmericaReiterates89.0
RNRJP MorganAssumes173.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

AllianceBernstein Reports EPS of $0.41 vs. $0.41 Estimate; Revenues $755.4M vs. $748.34M Estimate

Goldman Sachs Initiates Coverage On EXEL